Quarterly report [Sections 13 or 15(d)]

Schedule of Segment Information (Details)

v3.26.1
Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Segment Reporting [Line Items]      
Consolidated net revenue $ 1,169 $ 1,431  
Consolidated cost of revenue 874 905  
Total Depreciation and amortization expense 623 1,141  
Total  operating and other expenses 3,473 4,063  
Total loss from operations, before income taxes (3,801) (4,678)  
Income tax expense (1,374)  
Total loss from operations, after income taxes (5,175) (4,678)  
Net loss from continuing operations (5,175) (4,678)  
Unallocated corporate 58,467   $ 59,871
Total assets 58,467   59,871
Diagnostic Services Segment [Member]      
Segment Reporting [Line Items]      
Consolidated net revenue  
Consolidated cost of revenue 232  
Total Depreciation and amortization expense 334  
Total  operating and other expenses 168  
Total loss from operations, before income taxes (734)  
Consumer Products Segment [Member]      
Segment Reporting [Line Items]      
Consolidated net revenue 1,169 1,431  
Consolidated cost of revenue 874 673  
Total Depreciation and amortization expense 623 807  
Total  operating and other expenses 511 1,061  
Total loss from operations, before income taxes (839) (1,110)  
Unallocated corporate 10,973   11,614
Unallocated Corporate [Member]      
Segment Reporting [Line Items]      
Total  operating and other expenses 2,962 2,834  
Total loss from operations, before income taxes (2,962) $ (2,834)  
Unallocated corporate $ 47,494   $ 48,257